Apparatus is provided for treating a condition of an eye of a subject, comprising a stimulator adapted to stimulate at least one site of the subject, so as to treat the eye condition, the site selected from the list consisting of: a sphenopalatine ganglion (SPG) of the subject, an anterior ethmoidal
Apparatus is provided for treating a condition of an eye of a subject, comprising a stimulator adapted to stimulate at least one site of the subject, so as to treat the eye condition, the site selected from the list consisting of: a sphenopalatine ganglion (SPG) of the subject, an anterior ethmoidal nerve of the subject, a posterior ethmoidal nerve of the subject, a communicating branch between an anterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a communicating branch between a posterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a greater palatine nerve of the subject, a lesser palatine nerve of the subject, a sphenopalatine nerve of the subject, a communicating branch between a maxillary nerve and an SPG of the subject, a nasopalatine nerve of the subject, a posterior nasal nerve of the subject, an infraorbital nerve of the subject, an otic ganglion of the subject, an afferent fiber going into the otic ganglion of the subject, an efferent fiber going out of the otic ganglion of the subject, a vidian nerve of the subject, a greater superficial petrosal nerve of the subject, and a lesser deep petrosal nerve of the subject.
대표청구항▼
The invention claimed is: 1. A method for treating a condition of an eye of a subject, comprising: stimulating at least one site of the subject, so as to treat the eye condition, the site selected from the group consisting of: a sphenopalatine ganglion (SPG) of the subject, an anterior ethmoidal ne
The invention claimed is: 1. A method for treating a condition of an eye of a subject, comprising: stimulating at least one site of the subject, so as to treat the eye condition, the site selected from the group consisting of: a sphenopalatine ganglion (SPG) of the subject, an anterior ethmoidal nerve of the subject, a posterior ethmoidal nerve of the subject, a communicating branch between an anterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a communicating branch between a posterior ethmoidal nerve and a retro-orbital branch of an SPG of the subject, a greater palatine nerve of the subject, a lesser palatine nerve of the subject, a sphenopalatine nerve of the subject, a communicating branch between a maxillary nerve and an SPG of the subject, a nasopalatine nerve of the subject, a posterior nasal nerve of the subject, an infraorbital nerve of the subject, an otic ganglion of the subject, an afferent fiber going into the otic ganglion of the subject, an efferent fiber going out of the otic ganglion of the subject, a vidian nerve of the subject, a greater superficial petrosal nerve of the subject, and a lesser deep petrosal nerve of the subject, wherein stimulating the site comprises comprising the stimulation to cause an increase in a blood flow of the eye, so as to treat the eye condition. 2. A method according to claim 1, wherein the condition includes diabetic retinopathy, and wherein stimulating the site comprises stimulating the site so as to treat the diabetic retinopathy. 3. A method according to claim 1, wherein the condition includes retinal vein occlusion, and wherein stimulating the site comprises stimulating the site so as to treat the retinal vein occlusion. 4. A method according to claim 1, wherein the condition includes retinal artery occlusion, and wherein stimulating the site comprises stimulating the site so as to treat the retinal artery occlusion. 5. A method according to claim 1, wherein the condition includes retinal detachment, and wherein stimulating the site comprises stimulating the site so as to treat the retinal detachment. 6. A method according to claim 1, wherein the condition includes macular degeneration, and wherein stimulating the site comprises stimulating the site so as to treat the macular degeneration. 7. A method according to claim 1, wherein the condition includes glaucoma, and wherein stimulating the site comprises stimulating the site so as to treat the glaucoma. 8. A method according to claim 1, wherein the condition includes an optic neuropathy, and wherein stimulating the site comprises stimulating the site so as to treat the optic neuropathy. 9. A method according to claim 1, wherein the condition includes retinal degeneration, and wherein stimulating the site comprises stimulating the site so as to treat the retinal degeneration. 10. A method according to claim 1, wherein the condition includes cystoid macular edema (CME), and wherein stimulating the site comprises stimulating the site so as to treat the CME. 11. A method according to claim 1, wherein the condition includes a tumor of the eye, and wherein stimulating the site comprises stimulating the site so as to treat the tumor. 12. A method according to claim 11, wherein the condition includes a tumor of an optic nerve of the subject, and wherein stimulating the site comprises stimulating the site so as to treat the tumor of the optic nerve. 13. A method according to claim 11, wherein the condition includes retinal carcinoma, and wherein stimulating the site comprises stimulating the site so as to treat the retinal carcinoma. 14. A method according to claim 1, wherein stimulating the site comprises stimulating the SPG, so as to treat the eye condition. 15. A method according to claim 1, wherein stimulating the site comprises stimulating the anterior ethmoidal nerve, so as to treat the eye condition. 16. A method according to claim 1, wherein stimulating the site comprises stimulating the posterior ethmoidal nerve, so as to treat the eye condition. 17. A method according to claim 1, wherein stimulating the site comprises stimulating a site selected from the group consisting of: the communicating branch between the anterior ethmoidal nerve and the retro-orbital branch of the SPG, and the communicating branch between the posterior ethmoidal nerve and the retro-orbital branch of the SPG, so as to treat the eye condition. 18. A method according to claim 1, wherein stimulating the site comprises stimulating the greater palatine nerve, so as to treat the eye condition. 19. A method according to claim 1, wherein stimulating the site comprises stimulating the lesser palatine nerve, so as to treat the eye condition. 20. A method according to claim 1, wherein stimulating the site comprises stimulating the sphenopalatine nerve, so as to treat the eye condition. 21. A method according to claim 1, wherein stimulating the site comprises stimulating the communicating branch between the maxillary nerve and the SPG, so as to treat the eye condition. 22. A method according to claim 1, wherein stimulating the site comprises stimulating the nasopalatine nerve, so as to treat the eye condition. 23. A method according to claim 1, wherein stimulating the site comprises stimulating the posterior nasal nerve, so as to treat the eye condition. 24. A method according to claim 1, wherein stimulating the site comprises stimulating the infraorbital nerve, so as to treat the eye condition. 25. A method according to claim 1, wherein stimulating the site comprises stimulating the otic ganglion, so as to treat the eye condition. 26. A method according to claim 1, wherein stimulating the site comprises stimulating the afferent fiber going into the otic ganglion of the subject, so as to treat the eye condition. 27. A method according to claim 1, wherein stimulating the site comprises stimulating the efferent fiber going out of the otic ganglion of the subject, so as to treat the eye condition. 28. A method according to claim 1, wherein stimulating the site comprises stimulating the vidian nerve, so as to treat the eye condition. 29. A method according to claim 28, wherein stimulating the vidian nerve comprises stimulating the greater superficial petrosal nerve of the subject, so as to treat the eye condition. 30. A method according to claim 28, wherein stimulating the vidian nerve comprises stimulating the lesser deep petrosal nerve of the subject, so as to treat the eye condition. 31. A method according to claim 1, wherein stimulating the site comprises configuring the stimulation to cause an increase in cerebral blood flow (CBF) of the subject, so as to treat the eye condition. 32. A method according to claim 1, wherein stimulating the site comprises configuring the stimulation to cause an increase in molecular passage across a blood brain barrier (BBB) of the subject. 33. A method according to claim 32, wherein configuring the stimulation comprises configuring the stimulation such that the increased molecular passage across the BBB is of a magnitude that increases passage of a therapeutic agent from a systemic blood circulation of the patient through the BBB into a vicinity of the eye of the subject, so as to treat the eye condition. 34. A method according to claim 1, wherein stimulating the site comprises driving a current into the site. 35. A method according to claim 34, wherein driving the current comprises driving the current at a stimulation site in or adjacent to an orbital cavity of the subject. 36. A method according to claim 34, wherein driving the current comprises driving the current into an ethmoidal nerve of the subject. 37. A method according to claim 36, wherein driving the current comprises driving the current into an anterior ethmoidal nerve of the subject. 38. A method according to claim 36, wherein driving the current comprises driving the current into a posterior ethrnoidal nerve of the subject. 39. A method according to claim 34, wherein the site includes a first site and a second site, different from the first site, and wherein driving the current comprises driving the current between the first site and the second site. 40. A method according to claim 39, wherein the first site includes the vidian nerve of the subject, and the second site includes the SPG of the subject, and wherein driving the current comprises driving the current between the vidian nerve and the SPG. 41. A method according to claim 1, wherein stimulating the site comprises applying a neuroexcitatory agent to the site, so as to stimulate the site. 42. A method according to claim 41, wherein applying the neuroexcitatory agent comprises applying acetylcholine to the site, so as to stimulate the site. 43. A method according to claim 41, wherein applying the neuroexcitatory agent comprises applying urocholine to the site, so as to stimulate the site. 44. A method according to claim 1, wherein stimulating the site comprises applying mechanical stimulation to the site, so as to stimulate the site. 45. A method according to claim 44, wherein applying the mechanical stimulation comprises applying vibration to the site, so as to stimulate the site. 46. A method according to claim 1, wherein configuring the stimulation comprises configuring the stimulation such that the increased blood flow is of a magnitude that increases clearance of a substance from at least a portion of the eye, so as to treat the eye condition. 47. A method according to claim 46, wherein the substance includes a fluid contained in an anterior chamber of the eye, and wherein configuring the stimulation comprises configuring the stimulation to cause increased clearance of the fluid from the anterior chamber so as to lower an intraocular pressure of the eye, so as to treat the eye condition. 48. A method according to claim 1, wherein stimulating the at least one site comprises configuring the stimulation to induce parasympathetic activation of the at least one site. 49. A method according to claim 1, wherein stimulating the at least one site comprises configuring the stimulation to block parasympathetic neural activity of the at least one site.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (85)
Baker ; Jr. Ross G. (Houston TX) Terry ; Jr. Reese S. (Houston TX) Adkins Alan (Angleton TX), Activation techniques for implantable medical device.
Adkins Robert A. ; O'Donovan Cormac A. ; Terry ; Jr. Reese S., Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity.
Terry ; Jr. Reese F. (Houston TX) Stanislaw Henry (Blairstown NJ) Varrichio Anthony J. (Flanders NJ) Winstrom William L. (Andover NJ), Constant current sources with programmable voltage source.
Donald J. Hayes ; Ioan Achiriloaie ; David W. Taylor ; Norman Comparini ; David B. Wallace, Digital olfactometer and method for testing olfactory thresholds.
Whitehurst, Todd K.; McGivern, James P.; Woods, Carla Mann; Meadows, Paul M.; Kuzma, Janusz A., Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain.
Baker ; Jr. Ross G. (Houston TX) Terry ; Jr. Reese S. (Houston TX), Implantable medical device with dummy load for pre-implant testing in sterile package and facilitating electrical lead c.
Varrichio Anthony J. (Flanders NJ) Winstrom William L. (Andover NJ), Implanted apparatus disabling switching regulator operation to allow radio frequency signal reception.
Stanislaw Henry (Blairstown NJ), Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not p.
Robert E. Fischell ; David R. Fischell ; Adrian R. M. Upton CA; Dennis R. Potts ; Benjamin D. Pless, Means and method for the intracranial placement of a neurostimulator.
Fischell Robert E. ; Fischell David R. ; Morell Martha J. ; Gibb Barbara, Method for determining stimulation parameters for the treatment of epileptic seizures.
Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases.
David R. Fischell ; Jonathan Harwood ; Benjamin D. Pless, Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures.
Paradiso Peter R. (Pittsford NY) Hildreth Stephen W. (Rochester NY) Hu Branda T. (Pittsford NY) Martin-Gallardo Antonia (Silver Spring MD) Arumugham Rasappa (West Henrietta NY) Walsh Edward E. (Pitts, Respiratory syncytial virus vaccines.
Paradiso Peter R. (Pittsford NY) Hildreth Stephen W. (Rochester NY) Hu Branda T. (Pittsford NY) Martin-Gallardo Antonia (Pittsford NY) Arumugham Rasappa (West Henrietta NY), Respiratory syncytial virus: vaccines.
Pless, Benjamin D.; Archer, Stephen T.; Baysinger, Craig M.; Gibb, Barbara; Gurunathan, Suresh K.; Kirkpatrick, Bruce; Tcheng, Thomas K., Seizure sensing and detection using an implantable device.
Varrichio Anthony J. (Flanders NJ) Winstrom William L. (Andover NJ) Stanislaw Henry (Blairstown NJ), Simultaneous radio frequency and magnetic field microprocessor reset circuit.
Pless, Benjamin D.; Fischell, Robert E.; Fischell, David R., System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes.
Terry ; Jr. Reese S. (Houston TX) Wernicke Joachim F. (League City TX) Baker ; Jr. Ross G. (Houston TX), Therapeutic treatment of migraine symptoms by stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of eating disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of eating disorders by nerve stimulation.
Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX) Marquette Andre (Stamford CT), Treatment of motility disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Zabara Jacob (Philadelphia PA), Treatment of neuropsychiatric disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of patients in coma by nerve stimulation.
Loudin, James Donald; Franke, Manfred; Hamilton, Daniel N.; Doraiswamy, Anand; Ackermann, Douglas Michael, Contact lens for increasing tear production.
Friedland, Beth; Korb, Donald R.; Grenon, Steve; Jans, John; Gausmann, Keith; Willis, Timothy R., Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma.
Ackermann, Douglas Michael; Loudin, James Donald; Wardle, John; Baldwin, Jarren Armond; Hamilton, Daniel N.; Kuzma, Janusz; Stivers, Christopher William, Nasal stimulation devices and methods.
Loudin, James Donald; Hamilton, Daniel N.; Franke, Manfred; Ackermann, Douglas Michael, Nasal stimulation for rhinitis, nasal congestion, and ocular allergies.
Ackermann, Douglas Michael; Palanker, Daniel; Loudin, James Donald; Smith, Garrett Cale; McCray, Victor Wayne; Felkins, Brandon McNary, Systems and methods for treatment of dry eye.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.